7[alpha]-hydroxy-3-oxo-4-cholestenoic acid (7-HOCA) is a novel AKR1D1 substrate driving metabolic dysfunction and hepatocellular cancer risk in patients with non-alcoholic fatty liver disease (NAFLD)

Autor:	Nikolaos Nikolaou, Anastasia Arvaniti, Fabio Sanna, Conceicao Ismael da, Niall Dempster, Laura Gathercole, Jeremy Tomlinson
Rok vydání:	2022
Zdroj:	Endocrine Abstracts.
ISSN:	1479-6848
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::7158925c1d29d40d2382f4f747f1a055 https://doi.org/10.1530/endoabs.86.oc5.2 Zobrazit plný text záznamu